BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15060621)

  • 1. SRC gene expression in human cancer: the role of transcriptional activation.
    Dehm SM; Bonham K
    Biochem Cell Biol; 2004 Apr; 82(2):263-74. PubMed ID: 15060621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating SRC mutation in a subset of advanced human colon cancers.
    Irby RB; Mao W; Coppola D; Kang J; Loubeau JM; Trudeau W; Karl R; Fujita DJ; Jove R; Yeatman TJ
    Nat Genet; 1999 Feb; 21(2):187-90. PubMed ID: 9988270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
    J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling.
    Coluccia AM; Benati D; Dekhil H; De Filippo A; Lan C; Gambacorti-Passerini C
    Cancer Res; 2006 Feb; 66(4):2279-86. PubMed ID: 16489032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitous and tissue specific promoters of the human SRC gene are repressed by inhibitors of histone deacetylases.
    Kostyniuk CL; Dehm SM; Batten D; Bonham K
    Oncogene; 2002 Sep; 21(41):6340-7. PubMed ID: 12214274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional aspects of a tyrosine kinase encoding protooncogene, the c-src gene.
    Barnekow A
    Behring Inst Mitt; 1991 Jul; (89):67-73. PubMed ID: 1718257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of pp60c-src in 60 different cell lines derived from human tumors.
    Budde RJ; Ke S; Levin VA
    Cancer Biochem Biophys; 1994 Oct; 14(3):171-5. PubMed ID: 7537173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Src in solid and hematologic malignancies: development of new-generation Src inhibitors.
    Alvarez RH; Kantarjian HM; Cortes JE
    Cancer; 2006 Oct; 107(8):1918-29. PubMed ID: 16986126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of N-myristoyltransferase inhibitor protein and its relationship to c-Src levels in human colon cancer cell lines.
    Rajala RV; Dehm S; Bi X; Bonham K; Sharma RK
    Biochem Biophys Res Commun; 2000 Jul; 273(3):1116-20. PubMed ID: 10891381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR.
    Golubovskaya VM; Virnig C; Cance WG
    Mol Carcinog; 2008 Mar; 47(3):222-34. PubMed ID: 17849451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional activation of c-Fos by constitutively active Galpha(16)QL through a STAT1-dependent pathway.
    Lo RK; Wong YH
    Cell Signal; 2006 Dec; 18(12):2143-53. PubMed ID: 16781847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Src expression and activation in human cancer.
    Irby RB; Yeatman TJ
    Oncogene; 2000 Nov; 19(49):5636-42. PubMed ID: 11114744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of hTAFII68 (NTD)-mediated transactivation by v-Src.
    Lee HJ; Kim S; Pelletier J; Kim J
    FEBS Lett; 2004 Apr; 564(1-2):188-98. PubMed ID: 15094065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potential.
    Irby R; Mao W; Coppola D; Jove R; Gamero A; Cuthbertson D; Fujita DJ; Yeatman TJ
    Cell Growth Differ; 1997 Dec; 8(12):1287-95. PubMed ID: 9419417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
    Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
    Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Src transformation fingerprint in human colon cancer.
    Malek RL; Irby RB; Guo QM; Lee K; Wong S; He M; Tsai J; Frank B; Liu ET; Quackenbush J; Jove R; Yeatman TJ; Lee NH
    Oncogene; 2002 Oct; 21(47):7256-65. PubMed ID: 12370817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of human estrogen receptor alpha F promoter by a protein kinase C/c-Src-dependent mechanism in osteoblast-like cells.
    Longo M; Peruzzi B; Fortunati D; De Luca V; Denger S; Caselli G; Migliaccio S; Teti A
    J Mol Endocrinol; 2006 Dec; 37(3):489-502. PubMed ID: 17170089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors.
    Tan M; Li P; Sun M; Yin G; Yu D
    Oncogene; 2006 Jun; 25(23):3286-95. PubMed ID: 16407820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The detection of the c-src protein gene product in human lung tumors].
    Mazurenko NN; Kogan EA; Zborovskaia IB; Sukhova NM; Kiselev FL
    Vopr Onkol; 1991; 37(6):683-90. PubMed ID: 1726861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation.
    Darmoul D; Gratio V; Devaud H; Peiretti F; Laburthe M
    Mol Cancer Res; 2004 Sep; 2(9):514-22. PubMed ID: 15383630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.